Fact Meets Function

Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging.

This review article examined the role of nicotinamide mononucleotide (NMN) in aging processes and explored potential biological mechanisms through which NMN may influence age-related changes (Review). The authors synthesized evidence suggesting NMN acts as a NAD+ precursor that may affect cellular energy metabolism, mitochondrial function, sirtuins, and DNA repair pathways implicated in aging.

Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging. Read Post »

β-Nicotinamide mononucleotide supplementation prolongs the lifespan of prematurely aged mice and protects colon function in ageing mice.

This animal model study investigated β-nicotinamide mononucleotide (NMN) supplementation in mice with premature aging and age-related decline. Researchers found that NMN supplementation extended lifespan in prematurely aged mice and improved colon function in aging mice, suggesting potential effects on age-related physiological decline. This is **animal model evidence** and does not directly translate to human outcomes without further clinical investigation.

β-Nicotinamide mononucleotide supplementation prolongs the lifespan of prematurely aged mice and protects colon function in ageing mice. Read Post »

Toxicology study profile of Nicotinamide mononucleotide after acute and 90-day sub chronic dosing in Wistar rats and mutagenicity tests.

This in vitro and animal model study evaluated the safety profile of nicotinamide mononucleotide (NMN) through acute and 90-day sub-chronic dosing experiments in Wistar rats, along with mutagenicity testing. The research assessed toxicological endpoints including clinical signs, body weight changes, organ weights, blood chemistry, and genetic damage potential to establish safety parameters for NMN exposure. This evidence comes from animal model studies and in vitro mutagenicity assays, which represent preliminary safety data that typically precedes human clinical evaluation.

Toxicology study profile of Nicotinamide mononucleotide after acute and 90-day sub chronic dosing in Wistar rats and mutagenicity tests. Read Post »

The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.

This randomized, double-blind, placebo-controlled clinical trial evaluated the efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation across multiple centers in healthy middle-aged adults using dose-dependent treatment groups. The study assessed both safety outcomes and efficacy measures, with findings specific to how NMN supplementation affected the study population at varying doses. This evidence represents a human clinical trial, the highest level of evidence for establishing effects in human populations.

The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Read Post »

The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions.

This human clinical study examined nicotinamide mononucleotide (NMN) as a potential intervention for anti-aging, longevity, and chronic disease management by investigating its effects on cellular metabolism and age-related conditions. The research found that NMN demonstrated effects on NAD+ metabolism pathways associated with aging processes and chronic disease states. This evidence is classified as human clinical research.

The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions. Read Post »

Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns.

This review article examined nicotinamide mononucleotide (NMN) as a potential anti-aging intervention, evaluating both its proposed benefits and safety profile across available evidence. The authors identified promises in preclinical models and limited human data regarding metabolic and cardiovascular effects, while also highlighting gaps in long-term safety data and regulatory oversight for NMN as a commercial health product. This is a **review article** synthesizing existing literature rather than original human clinical research.

Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns. Read Post »

NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.

This review article examined the potential benefits and risks of NAD+ (nicotinamide adenine dinucleotide) therapeutic approaches, including NMN supplementation, across age-related degenerative diseases by analyzing existing clinical and preclinical evidence. The authors assessed both the rationale for NAD+ augmentation in aging-related conditions and identified potential safety concerns requiring consideration in therapeutic development. This is a **review article** synthesizing existing human clinical, animal model, and in vitro research rather than original research data.

NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Read Post »

[Anti-Aging Approach for Ocular Disorders: from Dry Eye to Retinitis Pigmentosa and Myopia].

This animal model study reviewed anti-aging approaches for treating various ocular disorders including dry eye disease, retinitis pigmentosa, and myopia, with investigation into compounds such as NMN (nicotinamide mononucleotide). The research examined how age-related cellular mechanisms contribute to these eye conditions and evaluated potential interventions targeting aging pathways. As an animal model study, these findings require further validation in human clinical trials before application to patient populations.

[Anti-Aging Approach for Ocular Disorders: from Dry Eye to Retinitis Pigmentosa and Myopia]. Read Post »

[Aging and homeostasis. Age-associated diseases and clinical application of NMN(Nicotinamide Mononucleotide).].

This review article examines the relationship between aging, homeostasis disruption, and age-associated diseases, with a focus on nicotinamide mononucleotide (NMN) as a potential clinical application (evidence level: review). The authors discuss how aging affects the body’s ability to maintain homeostasis and how this contributes to the development of chronic diseases, while exploring NMN’s proposed mechanisms in potentially addressing age-related physiological decline. The review synthesizes existing literature on NMN’s role in cellular energy metabolism and NAD+ restoration as it relates to aging and disease management.

[Aging and homeostasis. Age-associated diseases and clinical application of NMN(Nicotinamide Mononucleotide).]. Read Post »

Scroll to Top